Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-20 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-20/5
Series
Methodological standard
Version
1.0
Published
27 Jul 2025
Last reviewed
27 Jul 2025
Next review
27 Jul 2028
Identifier
10.71829/cei.meth.17
Certainty
High
Cycle
2025 Q3
Category
Stability

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Visible illumination delivered≥ 1.2 million lux hours, measuredAdequate challenge
Near-ultraviolet energy delivered≥ 200 W·h/m², measuredAdequate challenge
Dark-control degradationRecorded and subtractedSeparation of thermal from photolytic routes
Method suitability for photolytic degradantsDemonstrated under CEI-MS-13Detection capability

§5.2Acceptance criteria

  • A compound is designated light-sensitive where photolytic degradation in a transparent container exceeds the dark control by a margin the method can distinguish.
  • A light-sensitive compound requires an opaque or amber container and a light-protection statement on the certificate. The Institute has not assessed a research-supply certificate that carries one.

§5.3Limitations

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q1A(R2) Stability Testing of New Drug Substances and Products. ICH Harmonised Tripartite Guideline 2003;Step 4 version. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.